Program Description: 

This is a forum to review and learn about complex lymphoma cases and discuss them in a standard way with both pathological and radiological review. The goal of this multimodality approach is to insure that the best patient care is being delivered by Hematologists/Oncologists, Pathologists, Radiologists, and Radiation Oncologists.

 

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

 

 

 

 

Target audience: 
Physicians
Physician Assistants
Nurse Practitioners
Registered Nurses
Learning objectives: 

For Hematology/Oncology:
1. To improve my ability to order expensive diagnostic tests.
2. To develop multidisciplinary treatments for patients with complex lymphoid malignancies. 
3. To improve and maintain ability to recognize the salient morphologic, immunophenotypic, and cytogenetic features of common lymphoid malignancies. 
4. To review and update learning about methods and clinical practices of the radiation oncology group in the treatment of lymphoid malignancies. 

For Radiology:
1. To maintain and update knowledge about response criteria as it applies to patients with lymphoma.

For Hematopathology:
1. To maintain and update knowledge about therapeutic options and clinical trials regarding patients diagnosed in their service.

For Radiation Oncology:
1. To improve my ability to order expensive diagnostic tests.
2. To develop multidisciplinary treatments for patients with complex lymphoid malignancies. 
3. To improve and maintain ability to recognize the salient morphologic, immunophenotypic, and cytogenetic features of common lymphoid malignancies. 
4. To review and update learning about methods and clinical practices of the radiation oncology group in the treatment of lymphoid malignancies. 

 

Faculty & credentials: 

Activity Director:
Nirav Shah, MD

Planning Commitee Members:
Timothy Fenske, MD
Michael Holt, MD
Horatiu Olteanu, MD
Christopher Schultz, MD
Nirav Shah, MD

Speakers:
Timothy Fenske, MD
Alexandra Harrington, MD
Michael Holt, MD
Paul Hosking, MD
Horatiu Olteanu, MD
Christopher Schultz, MD
Nirav Shah, MD
 

All persons in control of content have NO relevant relationships to disclose with the exception of:

NameCompanyRole
Timothy Fenske, MDCelgene, SanofiConsultant, Speaker

 

In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.

 

Contact

Name: 
Erica Katuszonek
Phone number: 
+1 (414) 805-0348
Email: 
ekatuszonek@mcw.edu
Session date: 
09/26/2016 - 12:00pm to 1:00pm CDT
Location: 
Clinical Cancer Center
9200 W. Wisconsin Ave.
Conference Room K
Milwaukee, WI 53226
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.